Company Monitoring Page for Bayer

latest headlines for company on cafepharma

Bayer's billon-dollar Parkinson's disease bets land in the clinic
Fierce Biotech
Tue, 06/8/21 - 11:15 am
Tags:
Bayer, Parkinson's Disease, DA01, BlueRock Therapeutics
Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type
BioSpace
Sun, 06/6/21 - 10:31 pm
Tags:
Bayer, ASCO 2021, Vitrakvi, cancer
Bayer picks up radiotherapeutics biotech to prop up dwindling sales in prostate cancer program
Fierce Biotech
Thu, 06/3/21 - 10:50 am
Tags:
Bayer, radiotherapeutics, Noria Therapeutics, M&A, PSMA Therapeutics
Bayer’s investment arm leads digital health startup’s $90M round
MedCity News
Tue, 06/1/21 - 10:42 pm
Tags:
Bayer, digital health, artificial intelligence, Ada Health
Bayer backs Ada Health’s symptom checker app in $90m financing
Pharmaforum
Thu, 05/27/21 - 11:02 am
Tags:
Bayer, Ada Health, patients, venture capital, mobile apps
Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict
Fierce Pharma
Wed, 05/19/21 - 11:05 pm
Tags:
Baxalta, Takeda, hemophilia, patents, Bayer, Adynovate
Bayer sees jump in Essure adverse event reports gleaned from social media
Medtech Dive
Wed, 05/19/21 - 10:55 am
Tags:
Bayer, devices, Essure, contraceptives, social media, adverse events
Bayer (BAYRY) Inks Deal to Develop Therapies for Eye Diseases
Yahoo/Zacks.com
Tue, 05/18/21 - 11:15 pm
Tags:
Bayer, BlueRock Therapeutics, Fujifilm Cellular Dynamics, Opsis Therapeutics, cell therapy, eye diseases
ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients
Fierce Pharma
Sun, 05/16/21 - 11:32 pm
Tags:
Bayer, JNJ, ACC, Xarelto, bloodthinners
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Tags:
Bayer, finerenone, Farxiga, clinical trials, cardiovascular disease, myocardial infarction
Bay­er plots a ma­jor facelift at Berke­ley cam­pus, un­cork­ing a 30-year, $1.2B plan to dri­ve cell and gene ther­a­pies
Endpoints
Thu, 04/22/21 - 11:29 pm
Tags:
Bayer, Berkeley, cell therapy, gene therapy
Speak up, docs: Bayer's 'AMI' voice assistant talks prescription drug info for physicians
Fierce Pharma
Sun, 04/18/21 - 11:40 pm
Tags:
Bayer, physicians, pharma marketing, artificial intelligence
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
Tags:
AACR, Bayer, Aliqopa, non-Hodgkin lymphoma, follicular lymphoma, Zydelig
Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push
Fierce Biotech
Wed, 04/7/21 - 10:37 am
Tags:
Metagenomi, Bayer, funding, venture capital
Bayer unveils first look at its post-Xarelto, post-Eylea life—and it's better than expected
Fierce Pharma
Wed, 03/10/21 - 10:49 pm
Tags:
Bayer, Xarelto, Eylea, patents, Stivarga, Verquvo
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Tags:
Clarivate, Biogen, Eisai, aducanumab, UCB Pharma, bimekizumab, Relugolix, Pfizer, Takeda, Myovant, vericiguat, Bayer, Merck
Bayer’s gene therapy juggling act
EP Vantage
Mon, 02/8/21 - 10:35 am
Tags:
Bayer, gene therapy, AskBio
Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production
Xtalks
Fri, 02/5/21 - 10:48 am
Tags:
vaccines, COVID-19, drug manufacturing, Bayer, GSK, Sanofi, CureVac
Bayer agrees to help CureVac produce coronavirus vaccine
BioPharma Dive
Mon, 02/1/21 - 11:06 pm
Tags:
Bayer, CureVac, COVID-19, vaccines
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Endpoints
Wed, 01/27/21 - 11:29 am
Tags:
Bayer, Aimmune, peanut allergy, Ukko, Nestle

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.